Cue Biopharma (CUE) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by Interim President and CEO, with introductions of board members and meeting officials.

• Agenda included election of directors, ratification of auditor, executive compensation approval, and a reverse stock split proposal.

Shareholder proposals

• Four proposals presented: election of six directors, ratification of RSM US LLP as auditor for 2026, advisory approval of executive compensation, and approval of a reverse stock split within a 1-for-30 to 1-for-50 range.

Overview of voting outcomes

• All six director nominees were elected.

• Auditor ratification, executive compensation, and the reverse stock split amendment were all approved by shareholders.